Although cytotoxic chemotherapy eradicates most tumor cells, CSCs are more protected and capable to recapture the heterogenic tumor mass through self-renewal with high expression of aldehyde dehydrogenase 1 A (Aldh1A), CD133, CD44 and Sox2 [5–8]. The gene discussed is PROM1; the disease is neoplasm.